文献速递神经肿瘤

世界卫生组织I级颅底脑膜瘤不完全切除后的再生长因素

Regrowth factors of WHO grade I skull base meningiomas following incomplete resection.
PubMed 文献 · J Neurosurg · 2022-04-22

回顾性分析2005至2019年115例未接受辅助放疗的世界卫生组织I级颅底脑膜瘤不完全切除患者,最终80例纳入分析。再生长39例(48.7%),平均无再生长生存期50个月。Ki-67增殖指数≥4%与Simpson IV-V级切除是再生长独立预测因素,据此构建4组评分,评分1组平均无再生长生存期110个月,显著长于评分2-4组。

要点

  • Ki-67增殖指数≥4%与Simpson IV-V级切除是再生长独立预测因素
  • 4组评分平均无再生长生存期分别为110、70、38、9个月
  • 肿瘤质地、组织学、位置、瘤周水肿等对再生长无影响

核心结论

  • Ki-67增殖指数与Simpson切除分级与世界卫生组织I级颅底脑膜瘤不完全切除后的无再生长生存期显著相关。
  • Ki-67增殖指数与Simpson切除分级可用于分层评估再生长风险。

研究设计与样本

  • 回顾性分析2005至2019年710例新诊断世界卫生组织I级颅底脑膜瘤手术患者中115例(16.2%)不完全切除且未接受辅助放疗者,平均随访78个月(范围27-198个月)。
  • 排除失访10例和接受辅助放疗25例后,最终80例纳入分析。

主要发现

  • 再生长发生39例(48.7%),平均无再生长生存期50个月(范围3-191个月)。
  • 单因素分析显著预测因素包括Ki-67增殖指数≥4%(p=0.017)、Simpson IV和V级切除(p=0.005)、海绵窦侵犯(p=0.027)及Meckel腔侵犯(p=0.027)。
  • Cox回归分析仅Ki-67增殖指数≥4%(风险比9.39,p=0.003)和Simpson IV和V级切除(风险比8.65,p=0.001)显示无再生长生存期显著恶化。
  • 按4组评分分层,评分1(Ki-67增殖指数<4%且Simpson III级)、2(Ki-67增殖指数<4%且Simpson IV和V级)、3(Ki-67增殖指数≥4%且Simpson III级)、4(Ki-67增殖指数≥4%且Simpson IV和V级)的平均无再生长生存期分别为110、70、38、9个月。
  • 评分1组无再生长生存期显著长于评分2-4组(p<0.01);肿瘤质地、组织学、位置、瘤周水肿、血管包绕及端粒酶逆转录酶启动子突变对再生长无影响。

关键数值与推荐

  • Ki-67增殖指数≥4%的风险比为9.39(p=0.003)。
  • Simpson IV和V级切除的风险比为8.65(p=0.001)。
  • 评分1组平均无再生长生存期110个月,评分2组70个月,评分3组38个月,评分4组9个月。
  • 评分1组无再生长生存期显著长于评分2-4组(p<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of adjuvant radiation therapy following incomplete resection of WHO grade I skull base meningiomas (SBMs) is controversial, and little is known regarding the behavior of residual tumors. The authors investigated the factors that influence regrowth of residual WHO grade I SBMs following incomplete resection. METHODS: From 2005 to 2019, a total of 710 patients underwent surgery for newly diagnosed WHO grade I SBMs. The data of 115 patients (16.2%) with incomplete resection and without any adjuvant radiotherapy were retrospectively assessed during a mean follow-up of 78 months (range 27-198 months). Pre-, intra-, and postoperative clinical and molecular factors were analyzed for relevance to regrowth-free survival (RFS). RESULTS: Eighty patients were eligible for analysis, excluding those who were lost to follow-up (n = 10) or had adjuvant radiotherapy (n = 25). Regrowth occurred in 39 patients (48.7%), with a mean RFS of 50 months (range 3-191 months). Significant predictors of regrowth were Ki-67 proliferative index (PI) ≥ 4% (p = 0.017), Simpson resection grades IV and V (p = 0.005), and invasion of the cavernous sinus (p = 0.027) and Meckel's cave (p = 0.027). After Cox regression analysis, only Ki-67 PI ≥ 4% (hazard ratio [HR] 9.39, p = 0.003) and Simpson grades IV and V (HR 8.65, p = 0.001) showed significant deterioration of RFS. When stratified into 4 scoring groups, the mean RFSs were 110, 70, 38, and 9 months for scores 1 (Ki-67 PI < 4% and Simpson grade III), 2 (Ki-67 PI < 4% and Simpson grades IV and V), 3 (Ki-67 PI ≥ 4% and Simpson grade III), and 4 (Ki-67 PI ≥ 4% and Simpson grades IV and V), respectively. RFS was significantly longer for score 1 versus scores 2-4 (p < 0.01). Tumor consistency, histology, location, peritumoral edema, vascular encasement, and telomerase reverse transcriptase promoter mutation had no impact on regrowth. CONCLUSIONS: Ki-67 PI and Simpson resection grade showed significant associations with RFS for WHO grade I SBMs following incomplete resection. Ki-67 PI and Simpson resection grade could be utilized to stratify the level of risk for regrowth.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Park HH, Yoo J, Oh HC, et al. Regrowth factors of WHO grade I skull base meningiomas following incomplete resection. J Neurosurg. 2022. PMID: 35453107. doi:10.3171/2022.3.JNS2299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。